Annals of the ICRP
Volume 36, Issue 1 , Pages 61-67 , March 2006

Chapter 4

  • J. Valentin

      Affiliations

    • Corresponding Author InformationTel.: +46 8 729 7275; fax: +46 8 729 7298.

4.5. References 

  1. Boice JD, Blettner M, Kleinerman RA, et al. Radiation dose and leukemia risk in patients treated for cancer of the cervix. J. Natl. Cancer Inst. 1987;79:1295–1311
  2. Boice JD, Day NE, Andersen A, et al. Second cancers following radiation treatment for cervical cancer. An international collaboration among cancer registries. J. Natl. Cancer Inst. 1985;74:955–975
  3. Boice JD, Engholm G, Kleinerman RA, et al. Radiation dose and second cancer risk in patients treated for cancer of the cervix. Radiat. Res. 1988;116:3–55
  4. Bond VP, Fliedner TM, Archambeau JO. Mammalian Radiation Lethality: a Disturbance in Cellular Kinetics. New York: Academic Press; 1965;
  5. Brandao-Mello CE, Oliverira AR, Valverde NJ, Farina R, Cordeiro JM. Clinical and haematological aspects of 137Cs: the Goiania radiation accident. Health Phys. 1991;60:31–39
  6. Cai WB, Roberts SA, Bowley E, Hendry JH, Potten CS. Differential survival of murine small and large intestinal crypts following ionising radiation. Int. J. Radiat. Biol. 1997;71:145–155
  7. Casarett GW. Pathogenesis of radionuclide-induced tumors. In:  Sanders CL,  Busch RH,  Ballou JE,  Mahlum DD editor. Radionuclide Carcinogenesis. Springfield: National Technical Information Service (NTIS); 1973;p. 1–14
  8. Cross FT, Endres GWR, Sullivan MF. Dose to the GI tract from ingested insoluble beta emitters. Radiat. Res. 1978;73:37–50
  9. Darby SC, Doll R, Gill SK, et al. Long-term mortality after a single treatment course with X-rays in patients treated for ankylosing spondylitis. Br. J. Cancer. 1987;55:179–190
  10. Darby SC, Reeves U, Key T, Doll R, Stovall M. Mortality in a cohort of women given X-ray therapy for metropathia haemorrhagica. Int. J. Cancer. 1994;56:793–801
  11. Darby SC, Whitley E, Howe GR, et al. Radon and cancers other than lung cancer in underground miners: a collaborative analysis of 11 studies. J. Nat. Cancer Inst. 1995;87:378–384
  12. Davis FG, Boice JD, Urubec Z, et al. Cancer mortality in a radiation-exposed cohort of Massachusetts tuberculosis patients. Cancer Res. 1989;49:6130–6136
  13. Del Regato JA, Spjut HJ, Cox JD. Ackerman and del Regato’s Cancer Diagnosis Treatment and Prognosis. St. Louis, Missouri: The C.V. Mosby Co.; 1985;
  14. Fodde R, Smits R, Clevers H. APC, signal transduction and genetic instability in colorectal cancer. Nature Rev. 2001;1:55–67
  15. Gössner W. Target cells in internal dosimetry. Radiat. Protect. Dos. 2003;105:39–42
  16. Goyette MC, Cho K, Fasching CL, Levy DB, Kinzler KW, Paraskeva C, et al. Progression of colorectal cancer is associated with multiple tumor suppressor gene defects but inhibition of tumorigenicity is accomplished by correction of any single defect via chromosome transfer. Mol. Cell Biol. 1992;12:1387–1395
  17. Griem ML, Kleinerman RA, Boice JD, et al. Cancer following radiotherapy for peptic ulcer. J. Natl. Cancer Inst. 1994;86:842–849
  18. Hendry JH, Potten CS, Ghafoor A, Moore JV, Roberts SA, Williams PC. The response of murine intestinal crypts to short-range promethium-147 beta irradiation: deductions concerning clonogenic cell numbers and positions. Radiat. Res. 1989;118:364–374
  19. Hendry JH, Roberts SA, Potten CS. The clonogenic content of murine intestinal crypts: dependence on radiation dose used in its determination. Radiat. Res. 1992;132:115–119
  20. IAEA . The Radiological Accident in Goiania. Vienna: International Atomic Energy Agency; 1987;
  21. ICRP, 1992. The biological basis for dose limitation in the skin. ICRP Publication 59. Ann. ICRP 22(2).
  22. Inskip PD, Monson RR, Wagoner JK, et al. Cancer mortality following radium treatment for uterine bleeding. Radiat. Res. 1990;123:331–334
  23. Karam SM, Straiton T, Hassan WM, et al. Defining epithelial cell progenitors in the human oxyntic mucosa. Stem cells. 2003;21:322–336
  24. Lebedeva GA. Intestinal polyps arising under the influence of various kinds of ionising radiations. Vop. Onkol. 1973;19:47–51
  25. Maisin J, Maisin JR, Dunjic A. The gastrointestinal tract. In:  Berjis CC editors. Pathology of Irradiation. Baltimore: William and Wilkins; 1971;p. 296
  26. Merritt AJ, Potten CS, Watson AJ, Loh DY, Makayam K, Hickman JA. Differential expression of bcl-2 in intestinal epithelia. Correlation with attenuation of apoptosis in colonic crypts and the incidence of colonic neoplasia. J. Cell. Sci. 1995;108:2261–2271
  27. Modlin IM, Kidd M, Lye KD, et al. Gastric stem cells: an update. Keio J. Med. 2003;52:134–137
  28. Pochin, E.E., 1988. Sizewell B Inquiry. The Biological Bases of the Assumptions Made by NRPB in the Calculation of Health Effects. Proof of Evidence. National Radiological Protection Board, Chilton, UK, NRPB/P/2. Chilton.
  29. Potten CS. Structure, function and proliferative organisation of mammalian gut. In:  Potten CS,  Hendry JH editor. Radiation and Gut. Amsterdam: Elsevier; 1995;p. 1–31
  30. Potten CS, Li YQ, O’Connor PJ, Winton DJ. A possible explanation for the differential cancer incidence in the intestine, based on distribution of the cytotoxic effects of carcinogens in the murine large bowel. Carcinogenesis. 1992;13:2305–2312
  31. Preston SL, Wong W-M, Chan A, Poulson R, Jeffery R, Goodlad R, et al. Bottom-up histogenesis of colorectal adenomas: origin in the monocryptal adenoma and initial expansion by crypt fission. Cancer Res. 2003;63:3819–3825
  32. Richman S, Adlard J. Left and right sided large bowel cancer. BMJ. 2002;324:931–932
  33. Roberts SA, Hendry JH, Potten CS. The deduction of the clonogen content of intestinal crypts: a direct comparison of fractionated-dose and graded-dose methodologies. Radiat. Res. 1995;141:303–308
  34. Roberts SA, Hendry JH, Potten CS. Intestinal crypt clonogens: a new interpretation of radiation survival curve shape and clonogenic cell number. Cell Prolif. 2003;36:215–231
  35. Ron E, Preston DL, Mabuchi K, et al. Cancer incidence in atomic bomb survivors. Part IV. Comparison of cancer incidence and mortality. Radiat. Res. 1994;137:S98–S112
  36. Shih I-M, Wang T-L, Traverso G, Romans K, Hamilton SR, Ben-Sasson S, et al. Top-down morphogenesis of colorectal tumors. Proc. Natl. Acad. Sci. 2001;98:2640–2645
  37. Shimizu Y, Kato H, Schull WJ. Studies of the mortality of A-bomb survivors. Part 9: Mortality, 1950–1985. Part 2: Cancer mortality based on the recently revised doses (DS86). Radiat. Res. 1990;121:120–141
  38. Stebbings JH, Lucas HF, Stehney AF. Mortality from cancers of major sites in female radium dial workers. Am. J. Ind. Med. 1984;5:435–459
  39. Sullivan MF, Marks S, Hackett PL, Thompson RC. X-irradiation of the exteriorised or in situ intestine of the rat. Radiat. Res. 1959;73(11):653–666
  40. Sullivan MF, Ruemmber PS, Reamer JL, et al. Acute toxicity of beta-emitting radionuclides that may be released in a reactor accident and ingested. Radiat. Res. 1978;73:21–36
  41. Sullivan MF, Cross FT, Dagle GE. Dosimetry of the gastrointestinal tract. In:  Gerber GB,  Métivier H,  Smith H editor. Age-related Factors in Radionuclide Metabolism. Lancaster: Martinus Nijhoff; 1987;p. 49–66
  42. Thompson DE, Mabuchi K, Ron E, et al. Cancer incidence in atomic bomb survivors. Part II. Solid tumors, 1958–1987. Radiat. Res. 1994;137:S17–S67
  43. UNSCEAR . United Nations Scientific Committee on the Effects of Atomic Radiation. Sources, Effects and Risks of Ionizing Radiation. New York: United Nations; 1988;
  44. UNSCEAR . United Nations Scientific Committee on the Effects of Atomic Radiation. Sources and Effects of Ionizing Radiation. New York: United Nations; 2000;
  45. Vogelstein BE, Fearon ER, Hamilton SR, Kerr SE, Preisinger AC, Lepper TM, et al. Genetic alterations during colorectal-tumor development. N. Engl. J. Med. 1988;319:525–532
  46. Young RW. Acute radiation syndrome. In:  Conklin JJ,  Walker RI editor. Military Radiobiology. New York: Academic Press; 1987;

PII: S0146-6453(06)00011-X

doi: 10.1016/j.icrp.2006.03.007

Annals of the ICRP
Volume 36, Issue 1 , Pages 61-67 , March 2006